Copyright
©The Author(s) 2024.
World J Diabetes. Jul 15, 2024; 15(7): 1518-1530
Published online Jul 15, 2024. doi: 10.4239/wjd.v15.i7.1518
Published online Jul 15, 2024. doi: 10.4239/wjd.v15.i7.1518
Figure 2 Comparison of insulin changes before and after treatment in two groups of patients.
A: The changes in insulin resistance index before and after treatment in both groups; B: The changes in beta-cell function index before and after treatment in the two groups. cP < 0.001. HOMA-IS: Beta-cell function index; HOMA-IR: Insulin resistance index.
- Citation: Yu PL, Yu Y, Li S, Mu BC, Nan MH, Pang M. Dapagliflozin in heart failure and type 2 diabetes: Efficacy, cardiac and renal effects, safety. World J Diabetes 2024; 15(7): 1518-1530
- URL: https://www.wjgnet.com/1948-9358/full/v15/i7/1518.htm
- DOI: https://dx.doi.org/10.4239/wjd.v15.i7.1518